Avanos Medical, Inc. (AVNS) Misses Q4 EPS by 3c ; Offers Guidance

Avanos Medical, Inc. (NYSE: AVNS) reported Q4 EPS of $0.36, $0.03 worse than the analyst estimate of $0.39. Revenue for the quarter came in at $173.3 million versus the consensus estimate of $173.77 million.

GUIDANCE:

Avanos Medical, Inc. sees FY2024 EPS of $1.30-$1.45, versus the consensus of $1.38. Avanos Medical, Inc. sees FY2024 revenue of $685-705 million, versus the consensus of $690 million.

For earnings history and earnings-related data on Avanos Medical, Inc. (AVNS) click here.

You May Also Be Interested In

• Wex, Inc. (WEX) Tops Q2 EPS by 29c; raises guidance
• Crown Castle (CCI) Tops Q2 EPS by 30c; offers guidance
• Chemung Financial (CHMG) Tops Q2 EPS by 5c